Barry D. Plost
Geen lopende functies
Profiel
Barry D.
Plost began serving as Chairman of the board of directors and Chief Executive Officer of our company when Biomat USA, Inc. (formerly known as SeraCare, Inc.) acquired our company in February 1998.
From the time of our spin-off from Biomat USA in September 2001 until July 10, 2002, Mr. Plost served as our interim Chief Executive Officer.
Mr. Plost has served as Chairman, President and Chief Executive Officer of Biomat USA, Inc. since February 6, 1996.
Mr. Plost also serves on the PPTA Source board of directors of the Plasma Protein Therapeutics Association.
Mr. Plost also serves on the board of Probitas Pharma S.A.
and is a member of its Executive Committee.
Probitas Pharma S.A.
is the parent company of Instituto Grifols S.A., which purchased Biomat USA, and is a supplier to SeraCare Life Sciences.
Mr. Plost also became a consultant to the Company effective October 1, 2004.
Eerdere bekende functies van Barry D. Plost
| Bedrijven | Functie | Einde |
|---|---|---|
SeraCare Life Sciences, Inc.
 SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology SeraCare Life Sciences, Inc. provides in vitro diagnostics and clinical laboratory products. It supplies diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers. The firm’s products include Next-Gen Sequencing and Digital PCR Tools, Controls and Reference Materials, Validation and Lot Qualification Materials, Plasma and Serum Diluents/Derivatives, Cell Culture Reagents, KPL Antibodies and Conjugates and KPL Immunoassay Reagents and Kits. The company was founded in 1984 and is headquartered in Milford, MA. | Voorzitter | 15-03-2006 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
SeraCare Life Sciences, Inc.
SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology SeraCare Life Sciences, Inc. provides in vitro diagnostics and clinical laboratory products. It supplies diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers. The firm’s products include Next-Gen Sequencing and Digital PCR Tools, Controls and Reference Materials, Validation and Lot Qualification Materials, Plasma and Serum Diluents/Derivatives, Cell Culture Reagents, KPL Antibodies and Conjugates and KPL Immunoassay Reagents and Kits. The company was founded in 1984 and is headquartered in Milford, MA. | Health Technology |
